These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7701555)

  • 1. A history of the evolution of hepatitis C testing of blood donors: implications for the Canadian blood supply system.
    Preiksaitis JK; Rivet C
    Transfusion; 1995 Apr; 35(4):348-52. PubMed ID: 7701555
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sreening of blood for antibody to hepatitis B virus core antigen and prevention of post-transfusional hepatitis C before 1990].
    Echevarría Mayo JM; León Rega P
    Med Clin (Barc); 2003 Mar; 120(10):397. PubMed ID: 12681107
    [No Abstract]   [Full Text] [Related]  

  • 5. American Red Cross experience with routine testing for hepatitis B core antibody.
    AuBuchon JP; Sandler SG; Fang CT; Dodd RY
    Transfusion; 1989; 29(3):230-2. PubMed ID: 2493695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
    Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis following transfusion].
    Fürst G; Kostuch B; Peichl-Hoffmann G; Kellner S
    Beitr Infusionsther; 1988; 21():187-91. PubMed ID: 2462974
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group.
    Blajchman MA; Bull SB; Feinman SV
    Lancet; 1995 Jan; 345(8941):21-5. PubMed ID: 7528310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients.
    Mosley JW; Stevens CE; Aach RD; Hollinger FB; Mimms LT; Solomon LR; Barbosa LH; Nemo GJ
    Transfusion; 1995 Jan; 35(1):5-12. PubMed ID: 7998069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of anti-HBc testing of blood donors in Germany.
    Zeiler T; Karger R; Slonka J; Ketschmer V; Radsak K
    Transfus Med; 2006 Dec; 16(6):441-3. PubMed ID: 17163876
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-B post-transfusion hepatitis with hepatitis B core antibodies in donor blood.
    Katchaki JN; Siem TH; Brouwer R
    N Engl J Med; 1982 Sep; 307(10):628-9. PubMed ID: 6810169
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.
    Stevens CE; Aach RD; Hollinger FB; Mosley JW; Szmuness W; Kahn R; Werch J; Edwards V
    Ann Intern Med; 1984 Dec; 101(6):733-8. PubMed ID: 6437308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India.
    Rawat A; Diwaker P; Gogoi P; Singh B
    Indian J Med Res; 2017 Nov; 146(5):642-645. PubMed ID: 29512607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood.
    Vyas GN; Perkins HA
    N Engl J Med; 1982 Mar; 306(12):749-50. PubMed ID: 6801510
    [No Abstract]   [Full Text] [Related]  

  • 18. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
    Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
    Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.